FDA Supplement Label Compliance for Gummy Manufacturers: A Complete Guide

Why Gummy Supplement Labels Are Under Increased FDA Scrutiny

Gummy supplements have exploded in popularity over the last decade, and with that growth has come a proportional increase in FDA enforcement activity. Warning letters, import alerts, and mandatory recalls tied to labeling violations are no longer rare events in this category. The FDA does not treat gummy supplements differently from capsules or tablets under the law — they are still dietary supplements regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994 and manufactured under 21 CFR Part 111 — but the format creates unique compliance challenges that traditional label templates simply do not account for.

One of the most persistent problems is the "candy perception" issue. Because gummies look and taste like confections, manufacturers sometimes unconsciously apply food-label logic rather than supplement-label logic. Serving size declarations that mimic candy packaging, front-panel claims borrowed from snack food marketing, and ingredient lists that omit functional excipients are all common mistakes that trigger regulatory action. If your product has a Supplement Facts panel, every other element on that label must conform to dietary supplement labeling rules — full stop.

Beyond FDA, platforms like Amazon have layered on their own supplement compliance requirements, and third-party certification bodies like NSF International conduct label audits as part of GMP certification programs. Building a label that satisfies all of these stakeholders starts with understanding the foundational FDA requirements and then stress-testing your label against the gummy-specific variables that make this format uniquely complicated.

Mandatory Label Elements Under 21 CFR Part 101 and DSHEA

Every gummy supplement sold in the United States must display a specific set of information in specific locations on the label. The FDA defines the "principal display panel" (PDP) and the "information panel" separately, and requirements differ between them. Getting the geography of your label wrong is itself a violation, regardless of whether the content is accurate.

The following elements are required on every dietary supplement label:

• Statement of identity: The product must be clearly identified as a "Dietary Supplement" on the PDP. For gummies, this is frequently buried in small type or replaced with language like "Gummy Vitamins" — which is not compliant on its own.
• Net quantity of contents: Declared by count (e.g., "60 Gummies") on the PDP. Do not use weight as a substitute unless count is also present.
• Supplement Facts panel: Must follow the exact format specified in 21 CFR 101.36, including serving size, servings per container, and a full ingredient declaration with daily values where applicable.
• Ingredient list: All ingredients not listed in the Supplement Facts panel — including gelatin or pectin, natural flavors, citric acid, carnauba wax used in polishing, and coating agents — must appear in an "Other Ingredients" declaration in descending order of predominance by weight.
• Name and address of manufacturer, packer, or distributor: Required on the information panel. A domestic address or a qualifying statement ("Distributed by...") is acceptable.
• Directions for use: Required. For gummies, specify number of gummies per serving and any age or population restrictions.
• Warnings and cautions: Including the mandatory "Keep out of reach of children" statement and any allergen declarations required under FALCPA.

Allergen labeling deserves special attention in gummy manufacturing. Gelatin derived from pork or beef is not a major allergen under FALCPA, but it is a significant religious and dietary concern that can expose you to consumer complaints and retailer delistings. More critically, if your gummy formula uses any tree nuts, wheat-based glucose syrup, or milk-derived ingredients in coatings or flavoring systems, those allergens must be declared using "Contains" language or parenthetical identification in the ingredient list. Pectin-based gummies formulated for vegan positioning must also ensure the entire ingredient deck — including the bloom-controlled gelatin replacers, buffers, and co-gelling agents — is accurately reflected.

Supplement Facts Panel Accuracy: The Gummy-Specific Compliance Challenge

The Supplement Facts panel is where most gummy manufacturers encounter their most serious compliance risk, and the root cause is almost always a manufacturing variable rather than a labeling intent. Unlike a capsule or tablet where ingredient amounts are locked in at blending, gummy production introduces multiple points at which declared potency can drift. Cooking temperatures, moisture cook-down, depositing variation, and water activity management all affect the final concentration of active ingredients in each gummy unit.

Consider a vitamin C gummy formulated to deliver 500 mg per two-gummy serving. If the cooking process drives off more moisture than anticipated, the concentration per gram increases — and the actual per-gummy weight decreases — meaning the declared serving may no longer be geometrically correct. Conversely, if moisture retention is higher than spec, you may be under-delivering on label claim. This is not a hypothetical: FDA has cited gummy manufacturers specifically for products that tested outside the declared potency range, and the legal standard under 21 CFR Part 111 requires that finished product testing verify that the product meets label specifications before release.

To build a defensible Supplement Facts panel, gummy manufacturers should:

1. Establish overage percentages based on process validation data, not industry assumptions. Your gelatin- or pectin-based matrix behaves differently from a competitor's, and bloom strength, cook temperature, and depositing speed all interact to determine your final moisture profile.
2. Validate your target gummy weight at the depositing stage and set control limits tight enough that serving size declarations remain accurate across the full batch.
3. Test finished product potency using an accredited third-party laboratory before releasing inventory, and retain those records under 21 CFR 111.170 for a minimum of one year past the product's shelf life or two years past distribution, whichever is longer.
4. Review your serving size declaration against the Reference Amount Customarily Consumed (RACC) guidance and ensure your "per serving" column reflects what a consumer actually takes, not what produces a round number in the Supplement Facts panel.
5. Account for coating and polishing agents in your weight spec. A carnauba wax polish or a sugar-sanding step adds mass. If your Supplement Facts panel declares per-gummy weight, verify that the final coated gummy — not the deposited gummy — is what you tested.

One area that catches gummy manufacturers off guard is the treatment of added sugars. If your gummy formula contains tapioca syrup, corn syrup, cane sugar, or any other caloric sweetener, you are required to declare added sugars in your Supplement Facts panel under the updated nutrition labeling rules that now apply to dietary supplements as well as conventional foods. This caught a significant portion of the gummy supplement industry unprepared, and products with non-compliant panels continue to circulate in commerce.

Structure/Function Claims and Front-Panel Marketing Language

The front panel of a gummy supplement is prime marketing real estate, and the temptation to use aggressive claim language is understandable. But structure/function claims on dietary supplements are a heavily regulated space, and gummy products are not exempt from those rules simply because they are more consumer-friendly in format. The FDA distinguishes sharply between permissible structure/function claims, impermissible disease claims, and nutrient content claims — and all three categories appear routinely on gummy supplement packaging.

A permissible structure/function claim describes how a nutrient or ingredient affects the normal structure or function of the body. "Supports immune function" is a classic example. A disease claim — "Reduces your risk of heart disease" or "Clinically proven to treat anxiety" — is not permissible on a dietary supplement label without an approved health claim or qualified health claim petition. The line between these two categories is not always intuitive, and the FDA's warning letter database includes numerous gummy supplement companies cited for disease claims embedded in product names, website copy pulled into label QR codes, or Amazon listing content that the agency treats as labeling under its broad definition.

If you are using structure/function claims, you are required to:

• Notify FDA within 30 days of first marketing the product with the specific claim language
• Include the mandatory disclaimer: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."
• Ensure the disclaimer appears prominently and conspicuously — not in 6-point type at the bottom of a busy panel
• Maintain substantiation for every claim in your files, accessible during an FDA inspection

For gummy manufacturers selling through Amazon, this compliance layer is especially critical. Amazon's supplement compliance program requires structure/function claim substantiation as part of listing approval, and ASIN suppressions related to label claim issues are increasingly common. Having your label reviewed and your claim substantiation documented before you attempt to list is far less costly than an ASIN suppression during a product launch.

Building a Label Review and Change Control Process That Satisfies FDA and Retail Partners

A compliant label is not a one-time project — it is a living document that must be re-evaluated every time your formula changes, your supplier changes a raw material, your manufacturing process is modified, or new regulatory guidance is issued. Under 21 CFR Part 111, you are required to maintain written procedures for label review, and those procedures must be followed consistently. An FDA investigator reviewing your quality records will ask to see your label review SOPs, your label approval documentation, and evidence that the labels being applied in production match the approved master.

A robust label review process for a gummy supplement manufacturer should include at minimum:

• Initial label development review by a qualified regulatory professional before the label goes to print — this is not optional and should not be assigned to marketing without subject matter expertise involvement
• Formula linkage verification, confirming that every ingredient in the production formula (including mogul starch if any is incorporated, release agents, and coating components) is represented correctly on the label
• Finished product specification reconciliation, confirming that the Supplement Facts panel reflects validated finished-product test data, not just the theoretical formulation
• Change control triggers that automatically flag a label review when the formula, supplier, or manufacturing process changes — even changes that seem minor, like switching from one gelatin supplier to another with a different bloom strength, can affect your ingredient declaration
• Version control documentation linking each label version to the product lots manufactured under that label, enabling accurate recall scope identification if needed
• Periodic re-review on at least an annual basis to capture changes in FDA guidance, third-party retailer requirements, and emerging enforcement trends

At GummyGMP LLC, we work exclusively with gummy supplement manufacturers, which means we understand the specific intersection of production variables and label compliance in this format better than generalist consultants. If your label was designed before your process was fully validated, or if you have never formally reconciled your Supplement Facts panel against finished-product test data, those are the first two places to start. A label that looks compliant on paper but does not reflect what is actually in the gummy is not a compliant label — it is a future enforcement action waiting to happen.

Getting your labels right is one of the highest-leverage investments a gummy supplement manufacturer can make. It protects you from FDA warning letters, supports retail and e-commerce listing approvals, and builds the consumer trust that drives repeat purchases in a category where brand loyalty is increasingly tied to transparency and accuracy.